Key facts
- What it is
- A highly selective barrier between the blood and the brain tissue
- Formed by
- The tightly sealed cells lining the brain's capillaries
- Held together by
- Tight junctions, supported by astrocyte end-feet and pericytes
- Lets in
- Glucose, oxygen, and small lipid-soluble molecules, via transporters or diffusion
- Keeps out
- Most toxins, pathogens, large molecules, and many drugs
What the barrier is
The blood-brain barrier is not a single membrane or wall but a property of the blood vessels that thread through the brain. Everywhere else in the body, the walls of the smallest vessels, the capillaries, are somewhat leaky, letting fluid and small molecules pass freely between the blood and the surrounding tissue. In the brain, those same capillary walls are sealed almost watertight. The result is a border that the brain controls with great precision, admitting some substances and refusing others.
The purpose of this seal is protection and stability. Neurons signal by finely tuned shifts in ions and chemicals, and that signalling would be thrown into chaos if the brain's chemistry rose and fell with every meal or every fluctuation in the blood. The barrier holds the brain's internal environment steady, shields it from circulating toxins and infections, and keeps out molecules that would interfere with signalling. It is, in effect, a customs checkpoint around the most sensitive tissue in the body.
The scale of the interface is easy to underestimate. The brain is threaded with a dense mesh of capillaries so fine that almost no neuron sits far from one, giving a total vessel surface measured in many square metres folded into a small volume. Every point on that vast surface is sealed. The barrier is therefore not a single gate at the edge of the brain but a property spread across the entire vascular network within it, which is part of why it is so effective and so hard to circumvent.
How it is built
The barrier is the work of several cell types acting together, a partnership often called the neurovascular unit. Three players do most of the job.
Endothelial cells
The cells lining the inside of the capillary. In the brain they are joined by tight junctions and carry few of the pores and vesicles that make vessels leaky elsewhere, so they form a nearly continuous seal.
Tight junctions
Belts of protein that stitch neighbouring endothelial cells together, closing the gaps between them. They force any molecule entering the brain to go through the cells rather than slip between them.
Astrocytes and pericytes
Astrocyte end-feet wrap around the vessel and signal the endothelium to maintain the barrier, while pericytes embedded in the vessel wall regulate blood flow and help keep the seal tight.
Tight junction: a sealed contact between two adjacent cells that blocks substances from passing through the gap between them. In the brain's capillaries, tight junctions are what close off the usual leaky route, so nothing crosses without passing through the endothelial cells themselves. They are the structural heart of the barrier.
This layered design is what makes the barrier both strong and adjustable. The tight junctions provide the seal; the astrocytes and pericytes maintain and regulate it. Remove the astrocyte signals and the barrier weakens, which shows that the seal is not a fixed wall but a living, actively maintained state.
What it lets in and keeps out
The barrier is selective, not simply closed. A brain sealed off from everything would starve. Its task is to admit precisely what the brain needs while excluding what would harm it, and it does this molecule by molecule.
Let in
Oxygen and carbon dioxide, which cross freely. Glucose and amino acids, carried in by dedicated transporter proteins. Small, fat-soluble molecules, which can dissolve through the cell membranes. Water, within limits.
Kept out
Most bacteria and other pathogens. Many circulating toxins. Large molecules such as most proteins and antibodies. Water-soluble molecules that lack a transporter, including the great majority of drugs.
The theme is that entry is a privilege the brain grants deliberately. Fuel such as glucose does not diffuse in; it is escorted across by specific carriers. This means the barrier does not merely block, it actively chooses, and that selectivity is exactly what makes it so difficult to smuggle a medicine past.
Glucose is worth singling out, because the brain is unusually dependent on it. Neurons burn glucose almost exclusively for energy and hold very little in reserve, so a steady supply across the barrier is not a convenience but a necessity. A dedicated glucose transporter, present in large numbers in the brain's endothelial cells, keeps that supply flowing. It is a neat illustration of the barrier's logic: the more vital a substance, the more likely the brain has built a specific channel to admit it, while everything unrequested is left outside.
How molecules cross
Given so tight a seal, how does anything get through at all? There are a few routes, and which one a molecule can use depends on its size, its charge, and its solubility in fat.
Simple diffusion
Small, uncharged, fat-soluble molecules, including oxygen, carbon dioxide, and some drugs and anaesthetics, dissolve straight through the cell membranes. Being small and lipid-soluble is the classic passport into the brain.
Carrier transport
Essential nutrients that are not fat-soluble, such as glucose and certain amino acids, are ferried across by specific transporter proteins built into the endothelial cells. Each carrier is tuned to its cargo.
Receptor-mediated transport
Some large but vital molecules, such as insulin and iron-carrying transferrin, bind receptors that pull them across in vesicles. This route is a target for drug designers hoping to hitch a ride into the brain.
Active efflux
The barrier also works in reverse. Pumps such as P-glycoprotein grab certain molecules that have entered and eject them back into the blood, actively keeping many drugs out even after they slip in.
The upshot is a simple rule of thumb with important exceptions: to enter the brain unaided, a molecule should be small and fat-soluble. Anything else needs a dedicated transporter or a clever trick, and even then the efflux pumps may throw it back out.
Why it matters for medicine
For all its value in protecting the brain, the barrier is a formidable problem for treating it. The same seal that keeps out toxins keeps out most medicines, and this is one of the great obstacles in neurology and psychiatry.
The drug delivery problem: the large majority of small-molecule drugs, and virtually all large biological drugs such as antibodies, cannot cross the barrier in useful amounts. A treatment can be effective against a brain tumour or infection in the laboratory yet fail in the body simply because it cannot reach its target. Much of modern neuropharmacology is a search for ways across: designing molecules small and lipid-soluble enough to diffuse through, attaching drugs to natural transporters or receptors that will carry them, or temporarily and locally loosening the barrier so a drug can pass. Each strategy tries to solve the same puzzle: how to deliver a medicine to the one organ most carefully walled off from the blood.
The flip side is that the barrier also explains why some drugs have few brain effects by design. A medicine deliberately made unable to cross can act on the body while sparing the brain, avoiding drowsiness or other central effects. The barrier, then, is not only an obstacle but a tool that drug designers work both with and against.
Where the barrier is weaker
The barrier is not uniform. In a few small, specialised regions it is deliberately leaky, because those areas need direct contact with the blood to do their jobs. These are the circumventricular organs.
Circumventricular organ: one of several small regions around the brain's ventricles where the barrier is weak or absent. Here the brain is allowed a direct chemical window onto the blood, so it can sense the body's state or release hormones into the circulation.
These windows serve clear purposes. The area postrema, for instance, samples the blood for toxins and can trigger vomiting, a protective reflex that only works if that patch of brain can taste the bloodstream directly. Other such regions let the hypothalamus monitor hormones and signals of hunger, thirst, and salt balance, or release its own hormones into the blood. The exceptions, in other words, are not flaws but features: places where the brain needs to talk to the body chemically, and the barrier steps aside to let it.
When the barrier fails
Because the barrier is actively maintained, it can break down, and when it does, the consequences are serious. A leaky barrier lets in fluid, proteins, and cells that the brain normally excludes, and the results range from swelling to inflammation and neuronal injury.
After loss of blood flow
When part of the brain is deprived of blood, the barrier in that region is damaged. Fluid then leaks into the tissue, causing the swelling that often does much of the harm in the hours after a stroke.
Meningitis and encephalitis
Some pathogens breach the barrier to infect the brain, and the resulting inflammation loosens it further. This vicious circle lets more immune cells and fluid in, driving the swelling seen in serious brain infections.
In chronic disease
In conditions such as Alzheimer's and multiple sclerosis, the barrier grows leaky over time. This is increasingly seen not just as a symptom but as part of the disease process, letting harmful substances reach vulnerable neurons.
A breached barrier is therefore both a result and a cause. Injury or disease can damage it, and once damaged, it allows further injury, so protecting or repairing the barrier has become a goal of treatment in its own right. The gatekeeper, when it fails, becomes part of the danger it was built to hold back.
Sources
- Kandel ER, Koester JD, Mack SH, Siegelbaum SA. Principles of Neural Science. 6th ed. McGraw-Hill; 2021.
- Purves D, Augustine GJ, Fitzpatrick D, et al. Neuroscience. 6th ed. Oxford University Press; 2018.
- Abbott NJ, Patabendige AAK, Dolman DEM, Yusof SR, Begley DJ. Structure and function of the blood-brain barrier. Neurobiology of Disease. 2010;37(1):13-25.
This page is an educational reference. It is not medical advice and does not diagnose or treat any condition.